A deadly fungal meningitis outbreak apparently caused by tainted medication may present yet another hazard for patients, according to a NBC News story.
Officials with the U.S. Centers for Disease Control and Prevention report a relapse in an 80-year-old man who developed meningitis last year.
The CDC officials wrote of that case in a recent edition of the New England Journal of Medicine.
According to the CDC, the outbreak has read more.... --> continue reading...
A New York Times story about the link between certain diabetes drugs and pancreatic cancer, says that more than 100 lawsuits have been filed. According to the report, more than 575 plaintiffs around the country are claiming injury from Byetta, and more than 40 claim Januvia caused pancreatic cancer.
Meanwhile, Dr. Peter C. Butler, an internationally renowned diabetes expert who first sounded health warnings about the link is standing up to ...
continue reading...
The leading plaintiff trial lawyers association has expressed concerns to the U.S. Food and Drug Administration that a proposed regulatory change might prevent people injured by faulty all-metal hip implants from suing the manufacturers for damages.
The implants in question, such as those manufactured by Johnson & Johnson’s DePuy Orthopaedics subsidiary, have both a ball and a socket coated in a ...
continue reading...
A story in Men’s Journal explores the question of how people who use statins such as Lipitor should react to a recent study indicating that the cholesterol-lowering drugs may counteract the benefits of exercise.
The study in the Journal of the American College of Cardiology looked at a group of overweight, sedentary adults at risk of high cholesterol or high blood pressure. After a 12-week exercise program, a group of participants ...
continue reading...
The Wall Street Journal reports that Daiichi Sankyo Co., Japan’s third-largest pharmaceutical manufacturer, is hoping sales of new drugs will help the company offset lost revenue from patent expirations.
Although Daiichi Sankyo returned to profit in the fiscal fourth quarter and posted a six-fold jump in annual net profit, the story says, those gains were mainly due to the absence of a $3.9 billion one-time loss from settlement costs between its ...
continue reading...
A new study suggests that cholesterol-lowering drugs called statins, such as Pfizer’s Lipitor, may negate some of the fitness benefits of exercise.
A story in the New York Times says the study’s findings may present a tricky quandary where preventive health care is concerned. While statins are routinely prescribed for those with high cholesterol and other risk factors for heart disease, exercise is also generally recommended for warding off heart disease ...
continue reading...
